PrimeRFP SCOUT · Federal Contract Recompete Brief

W81K0022F0127COVID reagents BAMC fy23 — Gen-Probe Inc

Gen-Probe Inc holds $112.5M across 5,120 federal awards. This PIID sits alongside 3 related awards under parent W81K0421D0010. PoP ended Sep 30, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

W40m Usa Hca

Awarding office

Gen-Probe Inc

Recipient

Sep 30, 2023

PoP end

$1.3M

Obligated

$3.2M

Potential

334516

NAICS

6515

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Gen-Probe Inc — $90

Contract facts

Federal

Contract numberW81K0022F0127

Also listed asW81K00-22-F-0127

Also listed asW81K0421D0010-W81K0022F0127

AgencyW40m Usa Hca

Awarding officeW40m Usa Hca

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentGen-Probe Inc

CAGE0BDV3

UEIQNXWLAJDL4J3

NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6515

Parent IDIQ / IDVW81K0421D0010

Place of performanceSAN ANTONIO TX

Pricing typeFirm Fixed Price

Extent competedNot Competed

Related solicitationW81K0421R0018

PoP startOct 1, 2022

PoP end (current)Sep 30, 2023

Obligated$1.3M

Current value$3.2M

Potential value$3.2M

COVID REAGENTS BAMC FY23 is a federal award for W40m Usa Hca held by Gen-Probe Inc. Estimated value $3.2M ($1.3M obligated). Current period of performance ends Sep 30, 2023. Place of performance: SAN ANTONIO TX. Related solicitation W81K0421R0018.

Recompete timing

Public

● Past PoP end (1056 days ago)

Current PoP ended Sep 30, 2023 (1056 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Gen-Probe Inc — $112.5M obligated across 5,120 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)

Department of Defense (DOD)$719K · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

W81K0222P0032

NUCLEIC ACID ACTIVE REAGENTS AND ASSAY KITS FOR PANTHER AND FUSION INSTRUMENTS FOR TAMC 03…

$2.0M

Sep 30, 2026

N3239822P0303

EXERCISE OPTION YEAR 4 SERVICE AGREEMENT N3239822P0303 FOR: PANTHER FUSION (SN: 2090003912…

$122K

May 19, 2027

W81K0022P0111

KIT, APTIMA COMBO 2 CT/GC 250 TEST

$2.2M

Sep 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W81K0022F0127?

W81K0022F0127 (COVID reagents BAMC fy23) is a W40m Usa Hca award with a potential value of $3.2M, currently held by Gen-Probe Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W81K00-22-F-0127?

W81K00-22-F-0127 is the dashed form of PIID W81K0022F0127 (COVID reagents BAMC fy23), held by Gen-Probe Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W81K0022F0127?

W40m Usa Hca awarded W81K0022F0127 to Gen-Probe Inc (potential $3.2M).

Who is the incumbent on W81K0022F0127?

Gen-Probe Inc is the incumbent with $112.5M across 5120 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2023.

When does Gen-Probe Inc’s W81K0022F0127 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Apr 28, 2023